Get Started
To learn how Precision NanoSystems accelerates nanomedicine development from an idea to clinical applications, contact our Technical Sales Team.
Get in TouchExplore Novel Genetic
Medicine Formulations
Advanced microfluidics allows microliter formulation volumes with near complete sample recovery.
Simply pipette starting materials into wells, push a button, and pipette completed formulations out.
The Spark formulation process requires less than 10 seconds, allowing hundreds of formulations to be made in hours.
Electronic control minimizes batch-to-batch and user variability.
The Spark system is designed for operation in a sterile biosafety hood, so formulations can be made on-demand, and applied to cells in culture.
NxGen microfluidic mixing technology allows formulations to be scaled across the NanoAssemblr Platform to accelerate future development.
pipette in
cap
insert
push start
pipette out
dilute
optimize formulations for size
To learn how Precision NanoSystems accelerates nanomedicine development from an idea to clinical applications, contact our Technical Sales Team.
Get in Touch1
An aqueous phase and a miscible solvent containing dissolved nanoparticle precursors are injected into each inlet of the NanoAssemblr cartridge2
Under laminar flow, the two phases do not immediately mix3
Microscopic features engineered into the channel reproducibly control the mixing of the two streams4
Rapid, controlled, homogenous mixing produces homogeneous nanoparticles
Overview
NanoAssemblr Technology
Spark Demo
No cleaning or cleaning validation required: Cartridges are single-use and gamma irradiated for sterility. Available in packs of 20.
Neuro9 kits contain everything you need to encapsulate siRNA into clinically validated lipid nanoparticle (LNP) delivery systems. Kits include a proprietary ionizable cationic lipid.
Publication - Summary
April 04, 2019
The Journal of Neuroscience
Application Note
January 16, 2019
Publication - Abstract
November 01, 2018
Neuron
Poster
July 01, 2018
Publication - Abstract
May 25, 2018
Multiple Myeloma